Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20975373

Download in:

View as

General Info

PMID
20975373